New psoriasis drug shows promise for teens in Head-to-Head trial

NCT ID NCT06425549

Recruiting now Disease control Sponsor: UCB Biopharma SRL Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 30 times

Summary

This study tests a new drug called bimekizumab against an existing one (ustekinumab) for children and teens aged 6 to 17 with moderate to severe plaque psoriasis. The goal is to see if bimekizumab clears skin better at 16 weeks. About 168 participants will receive injections, and researchers will track skin improvement and side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Ps0021 20033
RECRUITING

Nagoya, Japan
Ps0021 20071
RECRUITING

Nagasaki, Japan
Ps0021 20337
RECRUITING

Shimotsuga-gun, Japan
Ps0021 40023
COMPLETED

Erlangen, Germany
Ps0021 40085
ACTIVE_NOT_RECRUITING

Pisa, Italy
Ps0021 40091
ACTIVE_NOT_RECRUITING

Nowa Sól, Poland
Ps0021 40121
ACTIVE_NOT_RECRUITING

Brussels, Belgium
Ps0021 40138
ACTIVE_NOT_RECRUITING

Bonn, Germany
Ps0021 40159
WITHDRAWN

Barcelona, Spain
Ps0021 40177
ACTIVE_NOT_RECRUITING

Münster, Germany
Ps0021 40249
ACTIVE_NOT_RECRUITING

Kiel, Germany
Ps0021 40334
ACTIVE_NOT_RECRUITING

Wroclaw, Poland
Ps0021 40356
ACTIVE_NOT_RECRUITING

Dresden, Germany
Ps0021 40420
WITHDRAWN

Liège, Belgium
Ps0021 40440
ACTIVE_NOT_RECRUITING

Ancona, Località Torrette, Italy
Ps0021 40515
COMPLETED

Berlin, Germany
Ps0021 40567
ACTIVE_NOT_RECRUITING

Roma, Italy
Ps0021 40625
ACTIVE_NOT_RECRUITING

Warsaw, Poland
Ps0021 40645
ACTIVE_NOT_RECRUITING

Frankfurt am Main, Germany
Ps0021 40737
ACTIVE_NOT_RECRUITING

Rzeszów, Poland
Ps0021 40738
ACTIVE_NOT_RECRUITING

Wroclaw, Poland
Ps0021 40740
ACTIVE_NOT_RECRUITING

Bad Bentheim, Germany
Ps0021 40741
ACTIVE_NOT_RECRUITING

Bialystok, Poland
Ps0021 40742
WITHDRAWN

Argenteuil, France
Ps0021 40743
ACTIVE_NOT_RECRUITING

Szczecin, Poland
Ps0021 40744
ACTIVE_NOT_RECRUITING

Kaposvár, Hungary
Ps0021 40745
ACTIVE_NOT_RECRUITING

Szeged, Hungary
Ps0021 40746
ACTIVE_NOT_RECRUITING

Debrecen, Hungary
Ps0021 40747
COMPLETED

Mainz, Germany
Ps0021 40748
ACTIVE_NOT_RECRUITING

Plzen-bory, Czechia
Ps0021 40749
ACTIVE_NOT_RECRUITING

Catania, Italy
Ps0021 40750
ACTIVE_NOT_RECRUITING

Alicante, Spain
Ps0021 40751
ACTIVE_NOT_RECRUITING

Esplugues de Llobregat, Spain
Ps0021 40752
COMPLETED

Granada, Spain
Ps0021 40753
WITHDRAWN

Santiago de Compostela, Spain
Ps0021 40754
WITHDRAWN

Nantes, France
Ps0021 40758
ACTIVE_NOT_RECRUITING

Hamburg, Germany
Ps0021 40832
ACTIVE_NOT_RECRUITING

Lodz, Poland
Ps0021 50084
ACTIVE_NOT_RECRUITING

Charleston, South Carolina, 29425, United States
Ps0021 50161
ACTIVE_NOT_RECRUITING

Los Angeles, California, 90045, United States
Ps0021 50162
ACTIVE_NOT_RECRUITING

Fountain Valley, California, 92708, United States
Ps0021 50196
COMPLETED

Northridge, California, 91325, United States
Ps0021 50201
COMPLETED

Arlington, Texas, 76011, United States
Ps0021 50344
ACTIVE_NOT_RECRUITING

Indianapolis, Indiana, 46250, United States
Ps0021 50355
ACTIVE_NOT_RECRUITING

Dallas, Texas, 75235, United States
Ps0021 50357
ACTIVE_NOT_RECRUITING

St. John's, Canada
Ps0021 50581
WITHDRAWN

Miami, Florida, 33165, United States
Ps0021 50599
WITHDRAWN

Kew Gardens, New York, 11415, United States
Ps0021 50617
WITHDRAWN

St. John's, Canada
Ps0021 50618
ACTIVE_NOT_RECRUITING

Mississauga, Canada

Conditions

Explore the condition pages connected to this study.

MODERATE TO SEVERE PLAQUE PSORIASIS